Element Pointe Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,693
Closed -$226K 98
2021
Q4
$226K Hold
5,693
0.07% 100
2021
Q3
$285K Hold
5,693
0.1% 86
2021
Q2
$320K Hold
5,693
0.1% 94
2021
Q1
$266K Hold
5,693
0.09% 102
2020
Q4
$248K Buy
+5,693
New +$210K 0.09% 95

Other funds holding HCAT

Element Pointe Advisors's HCAT Position: Q1 2022 in Review

Element Pointe Advisors sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 5,693 shares — an estimated $226K sold.

Element Pointe Advisors first reported a position in HCAT in Q4 2020 and held it in 5 quarters. The position peaked at $320K in Q2 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • Element Pointe Advisors reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
  • Element Pointe Advisors sold 5,693 Health Catalyst shares in Q1 2022, an estimated $226K.
  • Element Pointe Advisors first reported a position in Health Catalyst in Q4 2020 and held it in 5 quarters.
  • Element Pointe Advisors's Health Catalyst position peaked at $320K in Q2 2021.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Element Pointe Advisors's 13F filing for Q1 2022, filed 11 May 2022.